{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T05:40:18Z","timestamp":1756359618017,"version":"3.44.0"},"reference-count":14,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,7,3]]},"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:p>Currently, North America is facing a national opioid overdose crisis. Opioid use disorder (OUD) is a chronic, relapsing condition requiring varying intensities of treatment. Injectable opioid agonist therapy (iOAT) is an effective, high-intensity treatment option for people who are unsuccessful on conventional oral opioid agonist treatments (eg, methadone, buprenorphine). This case highlights the effectiveness of the provision of iOAT in a low-barrier setting. More specifically, we discuss a patient with severe OUD and untreated HIV infection, who was disengaged from medical care and, consequently, was prescribed iOAT in a supportive housing setting.<\/jats:p>","DOI":"10.1136\/bcr-2019-229456","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T11:25:19Z","timestamp":1564658719000},"page":"e229456","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorder"],"prefix":"10.1136","volume":"12","author":[{"given":"Rupinder","family":"Brar","sequence":"first","affiliation":[{"name":"Family Practice, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christy","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Family Practice, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seonaid","family":"Nolan","sequence":"additional","affiliation":[{"name":"Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"key":"2025082722145227000_12.7.e229456.1","unstructured":"Canada Public Health Agency. National report: apparent opioid-related deaths in Canada. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/apparent-opioid-related-deaths-report-2016-2017-december.html (Accessed 20 Aug 2018)."},{"key":"2025082722145227000_12.7.e229456.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61311-2"},{"key":"2025082722145227000_12.7.e229456.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.12.032"},{"key":"2025082722145227000_12.7.e229456.4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/ADM.0000000000000412","article-title":"Measuring the burden of opioid-related mortality in Ontario, Canada","volume":"12","author":"Gomes","year":"2018","journal-title":"J Addict Med"},{"key":"2025082722145227000_12.7.e229456.5","unstructured":"National Institute of Drug Abuse. Overdose Death Rates: National Institute of Drug Abuse. 2018 https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates (Accessed 20 Aug 2018)."},{"key":"2025082722145227000_12.7.e229456.6","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1016\/j.annemergmed.2017.07.281","article-title":"402 One-Year mortality of opioid overdose victims who received Naloxone by Emergency Medical Services","volume":"70","author":"Weiner","year":"2017","journal-title":"Ann Emerg Med"},{"key":"2025082722145227000_12.7.e229456.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60349-2"},{"key":"2025082722145227000_12.7.e229456.8","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.149195"},{"key":"2025082722145227000_12.7.e229456.9","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.110669"},{"key":"2025082722145227000_12.7.e229456.10","unstructured":"British Columbia Centre on Substance Use. Guidance for injectable opioid agonist treatment for opioid use disorder. 2017 http:\/\/www.bccsu.ca\/wp-content\/uploads\/2017\/06\/BC-OUD-Guidelines_June2017.pdf (Accessed 20 Aug 2018)."},{"key":"2025082722145227000_12.7.e229456.11","unstructured":"Strang J , Groshkova T , Metrebian N . New heroin-assisted treatment: recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond. 170. Luxembourg: Publications Office of the European Union, 2012."},{"key":"2025082722145227000_12.7.e229456.12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jsat.2005.09.003","article-title":"Heroin maintenance treatment for chronic heroin-dependent individuals: a Cochrane systematic review of effectiveness","volume":"30","author":"Ferri","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"2025082722145227000_12.7.e229456.13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40429-018-0231-x","article-title":"The threat of an international opioid crisis","volume":"5","author":"Nolan","year":"2018","journal-title":"Curr Addict Rep"},{"key":"2025082722145227000_12.7.e229456.14","unstructured":"Strang J , Groshkova T , Metrebia N . New heroin-assisted treatment. Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond European Monitoring Centre for Drugs and Drug Addiction. 2012."}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-229456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T05:15:03Z","timestamp":1756358103000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-229456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":14,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,8,1]]},"published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1136\/bcr-2019-229456"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-229456","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}